Company / Cash per Share
Biogen Cash per Share History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$13.78
FY2019
5-year range
-
FY2016-FY2019
Trend
+142.9%
vs FY2018
Sector context
#13 of 207
Health Care
What the data says
Among 207 Health Care companies, Biogen is in the top 6% for cash per share. Cash per Share returned to growth in FY2019 after 2 years of decline, reaching $13.78.
Based on SEC 10-K filings.
13.78 in FY2019 with a 3-year CAGR of +9.0%. Top quartile in the Health Care sector.
Improved from $7.29 to $13.78 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +9.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 207This company $13.78 Sector average $67.39
▼
-79.6% below sector average
Key checks
Key Insights
- In FY2019, cash per share increased 142.9% year-over-year.
- Ranks #13 out of 207 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $13.78 | +142.9% |
| FY2018 | $5.67 | -22.2% |
| FY2017 | $7.29 | -31.5% |
| FY2016 | $10.64 | +90.9% |
As of FY2019 · SEC 10-K · Updated Mar 3, 2026